PHILIP CHILDERS: Open Payments
NPI 1205347390 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 21 payments from 8 companies in 2025. Trend: 2023 $1,013 · 2024 $517 · 2025 $581
Food & beverage: $513Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $140 |
| TOLMAR, INC. | 5 | $112 |
| Travere Therapeutics, Inc. | 1 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Endo USA, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Teleflex LLC | 1 | $17 |
Products named: ERLEADA, Filspari, JATENZO, Nubeqa, XIAFLEX, XTANDI, ORGOVYX, ELIGARD.
Industry payments across AR — which companies pay providers there.
